Group items tagged

The General Pharmaceutical Council (GPhC) has called for comments and views on the recently launched consultation on selecting the appropriate mode of consultation when assessing a person's needs by pharmacy professionals including pharmacist prescribers. The guidance note sets out what the pharmacy professional or prescriber, in agreement with the patient, needs to consider when selecting the mode of consultation - such as face-to-face; video-link, video-chat, or other online platforms; telephone and online questionnaires - best suited to gaining the information needed to deliver safe and effective pharmacy care. The principles outlined in the guidance apply to consultations undertaken in all pharmacy settings, including those undertaken by online pharmacy services providers. "Our plan is to include the contents of this guidance note in the document: 'In practice: Guidance for pharmacist prescribers' when we undertake our next review," said the regulator.

The Medicines and Healthcare products Regulatory Agency (MHRA) has been accepted as a full member of three international work-sharing partnerships. Through these partnerships the agency said it will play vital international role in making sure medicines and medical devices are regulated safely and efficiently worldwide, Two of these, the International Medical Device Regulatory Forum (IMDRF) and the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) are focused on improving the harmonisation and convergence of medicines and medical devices regulation globally. The partnerships will also help the MHRA to share expertise with other leading organisations, support the development of regulatory guidelines and drive greater harmonisation of regulation around the world. This will help deliver timely access to innovative medical products not just in the UK but globally.

If you're thinking of heading a startup, owning a local pharmacy could be an incredibly lucrative opportunity. When you set up a business in the healthcare sector, it's important to ensure that you operate with transparency to keep yourself and your patients safe. Whether you've acquired pharmacies before or you're turning to a new venture with different partners, learning the relevant steps before getting involved is imperative. Successful pharmacies rely on medical expertise, professional knowledge, and an excellent quality of service. Step 1: Do you need qualifications to be a pharmacist? No matter if you already have a background in pharmacy or you're entering the field from an entrepreneurial perspective, you'll need to have the right qualifications. You can become a pharmacist by completing a Master of Pharmacy degree at a university. Your chosen course needs to be approved by the General Pharmaceutical Council and will take at least four years to complete. After your degree, you'll also need to take the one-year pharmacist foundation training scheme. To access these courses, you'll usually need two or three A levels, including Chemistry. Alternatively, you could do a pharmacy foundation degree if you only have one A level or equivalent.

A BBC investigation has found 20 UK online pharmacies selling prescription-only medicines without adhering to the regulatory standards, such as checking for GP approval or patient's medical records. The news organisation was able to purchase over 1,600 restricted pills, including anti-anxiety drug, painkiller and sleeping medication, from these regulated online pharmacies easily by providing false information. However, the report didn't mention the names of the drugs as "they can be dangerous when taken without medical guidance." Some pharmacies were also found selling high-risk and potentially addictive medicines, including benzodiazepines and antidepressants, based on online questionnaires and did not require further checks. The General Pharmaceutical Council (GPhC), which regulate online pharmacies in the UK, states that selling and supplying medicines at a distance brings "different risks which need to be appropriately managed to protect patient safety."

The Pharmacist's Defence Association (PDA) has raised concerns over the adoption of Digital Clinical Excellence (DiCE) guidelines for online prescribing of GLP-1 receptor agonists for weight management in adults. This follows a clash with expert recommendations commissioned by the General Pharmaceutical Council (GPhC) as the PDA "believes the final guidance conflicts with the expert opinion underpins the GPhC's prosecution strategy towards pharmacist prescribers under investigation." In a recent statement, the PDA highlighted the discrepancy between DiCE's guidance and the expert report employed by the GPhC to prosecute pharmacist prescribers using a questionnaire-based consultation model. This conflict has prompted the PDA to withhold its endorsement of the DiCE guidance as it differs from an expert report commissioned by the GPhC. The PDA's reservations stem from the inherent risks associated with questionnaire-based prescribing.

NHS England's decision to forgo commissioning puberty suppressing hormones (PSH) for children and young people, citing insufficient evidence of their safety and clinical effectiveness, follows a comprehensive review conducted by the National Institute for Health and Care Excellence (NICE) in 2020. The clinical report underscores that "PSH treatment options will not be part of routine commissioning" for people under the age of 18 in England grappling with gender incongruence or dysphoria. The NHS England review analysed nine observational studies on Gonadotrophin Releasing Hormone Analogues (GnRHa) and found no statistically significant difference in gender dysphoria, mental health, body image, and psychosocial functioning among children and adolescents treated with GnRHa. Duncan Rudkin, chief executive of the General Pharmaceutical Council (GPhC), acknowledged the challenges faced by pharmacy professionals regarding prescriptions for puberty suppressing hormones, stating:

The General Pharmaceutical Council (GPhC) has launched a consultation on changes to the quality assurance processes of pharmacy education and training. In its consultation published on 4 April 2024, the pharmacy regulator has proposed four key changes to the procedures, including annual monitoring of all pharmacy education providers, including pharmacy schools offering MPharm courses. The annual audit will enable the GPhC "to identify and address concerns together with providers in a more timely, proportionate and systematic manner". It is considering collecting yearly data, including feedback from students, trainees, supervisors and patients, from educational organisations. The GPhC has also proposed defining clear lines of responsibility and criteria for determining whether to re-approve a course or qualification.

In a bid to bolster the educational experience for undergraduate pharmacy students across London, Kingston University has embarked on a groundbreaking project in collaboration with University College London and King's College London. This initiative, fueled by a substantial £1.5 million investment from National Health Services England (NHSE), aims to elevate the quality and consistency of pharmacy placements throughout the capital for new pharmacy entrants. The project is designed to address the evolving standards set forth by the General Pharmaceutical Council (GphC), ensuring that newly-trained pharmacists are well-prepared to meet the demands of their profession. By standardizing and expanding pharmacy placements, the three universities seek to provide students with a comprehensive and diverse range of "experiential learning opportunities".

The implementation of the 2017 standards for the initial education and training of pharmacy technicians (IETPT) has improved the performance and preparedness for practice among recently registered pharmacy technicians and the wider workforce, according to a new study. Results of the 2023 research study commissioned by the General Pharmaceutical Council (GPhC) showed that 72 per cent of pharmacy technicians felt "well prepared" for practice after training. More number of pharmacy technicians in the community pharmacy expressed readiness for practice (82 per cent) than their peers in the hospital pharmacy (64 peer cent). Led by the Centre for Pharmacy Workforce Studies (CPWS) at the University of Manchester and the consultancy service, ICF, the study involved 142 recently registered pharmacy technicians and 21 employers and supervisors of trainees. Overall, 96 per cent of the surveyed respondents believed that the course effectively covered person-centred care, professionalism and professional knowledge and skills.

The General Pharmaceutical Council (GPhC) has developed new draft Standards for Chief Pharmacists to strengthen pharmacy governance. It has set out the professional responsibilities as well as described the knowledge, conduct, and performance required by a chief pharmacist (or equivalent) to support their organisation and its staff to deliver "safe and effective" pharmacy services. The pharmacy regulator has also launched a consultation to find out what patients, carers, and members of the public think about the new draft standards. Participants can share their views "if there are any settings in which the standards could not be applied or met and any positive or negative impacts of the proposals," it said. The survey will open for 12 weeks, from 23 January to 16 April 2024.

Trainee pharmacists across Great Britain are preparing to participate in Pharmacist Support's annual Trainee ACTNow Wellbeing Campaign, scheduled from May 20th to 24th. Organised by the charity, this initiative aims to provide essential support as trainees approach the culmination of their placements and gear up for the General Pharmaceutical Council (GPhC) assessment. Danielle Hunt, Chief Executive of Pharmacist Support, highlighted the campaign's focus on addressing the significant stress and pressure trainees may experience during this critical period. She stated: "We understand the anxiety and pressure they may feel, not only in preparing for the assessment but also in stepping into their roles as registered pharmacists."

A recent report published by the General Pharmaceutical Council (GPhC) has highlighted a significant increase in the number of registered pharmacists and pharmacy technicians, indicating the expanding role of these professionals in the UK healthcare system. As of May 31, 2024, the GPhC register recorded a total of 90,739 pharmacy professionals, up from 90,604 at the end of April 2024. This includes 64,415 pharmacists and 26,324 pharmacy technicians, maintaining a steady split of 71 per cent pharmacists and 29 per cent pharmacy technicians. This reflects an overall increase of four pharmacists and 131 pharmacy technicians from the previous month. The report underscores the critical role of pharmacy professionals in ensuring high-quality patient care and supporting the operational efficiency of pharmacies.

The General Pharmaceutical Council (GPhC) has produced a new resource to support pharmacists and pharmacy technicians who are providing pharmacy services to children and young people with gender incongruence or dysphoria. It emphasises that pharmacy teams providing such services need to adhere to the standard process of clinical assessment and care provision they have been trained to take as healthcare professionals. The starting point is that pharmacy professionals must provide compassionate, inclusive and person-centred care, within the current relevant legal and regulatory context. "It's essential that all patients have access to appropriate, high-quality and respectful healthcare, free from discrimination or bias," the GPhC noted

The General Pharmaceutical Council (GPhC) has alerted pharmacists, pharmacy technicians, and pharmacy owners via email regarding new emergency legislation governing the prescribing and supply of puberty-suppressing hormones, commonly known as 'puberty blockers', for children and young people under 18 in England, Wales, and Scotland. The regulations apply to gonadotropin-releasing hormone (GnRH) analogues, used to suppress puberty as part of treating gender incongruence or gender dysphoria in individuals under 18. Effective from 3 June 2024, new private prescriptions for GnRH analogues from prescribers in the European Economic Area (EEA) or Switzerland who are not UK registered are banned from being dispensed in Great Britain for patients under 18. The emergency ban on these medicines will remain in effect until September 3, 2024, the Department of Health and Social Care (DHSC) announced on 29 May, stating that the action has been taken to address risks to "patient safety."

Pharmacy2U has recently acquired LloydsDirect in a confidential deal, bringing together two of the UK's foremost online pharmacies. Over time, both entities will integrate their operations under the Pharmacy2U brand, the companies said in a joint statement. The two businesses complement each other effectively, and their teams will now work closely together to uphold the patient-centric approach and service quality for which both are known individually, the statement added. However, there is currently limited clarity regarding the sale process and its impact on Lloyds staff. According to NHS Business Services Authority data from PharmData, Pharmacy2U dispensed 1,528,436 items in June 2023, while LloydsDirect, previously owned by LloydsPharmacy, dispensed 1,142,891 items. This positions them as the top two online prescription pharmacies for items dispensed, with Well.co.uk in third place at 128,691 items.